|
Gland Pharma Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
27637.89 Cr.
|
P/BV
|
2.81
|
Book Value (Rs.)
|
596.28
|
|
52 Week High/Low (Rs.)
|
2131/1278
|
FV/ML
|
1/1
|
P/E(X)
|
39.57
|
|
Bookclosure
|
14/08/2025
|
EPS (Rs.)
|
42.40
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 4687.86 | 4191.60 | 4127.27 | 2839.59 | 3297.69 |
| Total Income From Operations | 4687.86 | 4191.60 | 4127.27 | 2839.59 | 3297.69 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 1645.68 | 1384.91 | 1447.45 | 1278.37 | 1443.91 |
| Purchase of Traded Goods | 4.33 | 11.39 | 16.31 | 12.44 | 16.86 |
| Increase/Decrease in Stocks | 1.59 | 206.13 | 109.95 | 29.78 | 103.16 |
| Power & Fuel | 149.83 | 146.55 | 64.04 | 0.00 | 0.00 |
| Employees Cost | 1217.27 | 1028.19 | 905.29 | 300.44 | 244.32 |
| Depreciation | 315.01 | 282.11 | 251.96 | 109.19 | 79.22 |
| Other Expenses | 552.64 | 493.01 | 609.82 | 362.22 | 327.66 |
| Total Expenses | 3886.34 | 3552.30 | 3404.81 | 2092.44 | 2215.12 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 801.52 | 639.30 | 722.47 | 747.15 | 1082.57 |
| Other Income | 204.86 | 169.58 | 128.09 | 201.52 | 158.70 |
| P/L Before Interest, Excpt. Items & Tax | 1006.38 | 808.88 | 850.55 | 948.68 | 1241.28 |
| Interest | 23.25 | 34.55 | 16.24 | 5.24 | 3.21 |
| P/L Before Exceptional Items & Tax | 983.13 | 774.33 | 834.31 | 943.43 | 1238.07 |
| Exceptional Items | -24.35 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/L Before Tax | 958.78 | 774.33 | 834.31 | 943.43 | 1238.07 |
| Tax | 298.14 | 262.34 | 254.27 | 241.07 | 312.31 |
| P/L After Tax from Ordinary Activities | 660.64 | 511.99 | 580.04 | 702.36 | 925.76 |
| Net Profit/Loss For the Period | 660.64 | 511.99 | 580.04 | 702.36 | 925.76 |
| Net P/L After Minority Interest & Share Of Associates | 660.64 | 511.99 | 580.04 | 702.36 | 925.76 |
| | | | | | |
| Equity Share Capital | 16.48 | 16.48 | 16.47 | 16.47 | 16.43 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 40.10 | 31.08 | 35.22 | 42.67 | 56.41 |
| Diluted EPS (Rs.) | 40.10 | 31.08 | 35.21 | 42.65 | 56.41 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 40.10 | 31.08 | 35.22 | 42.67 | 56.41 |
| Diluted EPS (Rs.) | 40.10 | 31.08 | 35.21 | 42.65 | 56.41 |
| | | | | | |
| PBITOE Margin (%) | 17.09 | 15.25 | 17.50 | 26.31 | 32.82 |
| PBTE Margin (%) | 20.97 | 18.47 | 20.21 | 33.22 | 37.54 |
| PBT Margin (%) | 20.45 | 18.47 | 20.21 | 33.22 | 37.54 |
| PAT Margin (%) | 14.09 | 12.21 | 14.05 | 24.73 | 28.07 |
| PAT After MI And SOA Margin (%) | 14.09 | 12.21 | 14.05 | 24.73 | 28.07 |